Quansheng Zhou

4.6k total citations
89 papers, 3.7k citations indexed

About

Quansheng Zhou is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Quansheng Zhou has authored 89 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 26 papers in Immunology and 20 papers in Oncology. Recurrent topics in Quansheng Zhou's work include Angiogenesis and VEGF in Cancer (12 papers), Immunotherapy and Immune Responses (8 papers) and Phagocytosis and Immune Regulation (8 papers). Quansheng Zhou is often cited by papers focused on Angiogenesis and VEGF in Cancer (12 papers), Immunotherapy and Immune Responses (8 papers) and Phagocytosis and Immune Regulation (8 papers). Quansheng Zhou collaborates with scholars based in China, United States and Bangladesh. Quansheng Zhou's co-authors include Peter J. Sims, Therese Wiedmer, Ji Zhao, Zhifei Cao, Ping Yang, Zhiwei Wang, James G. Stout, Gaochuan Zhang, Meimei Bao and Bingxue Shang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Quansheng Zhou

89 papers receiving 3.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Quansheng Zhou 2.3k 871 640 519 433 89 3.7k
Arshad Rahman 2.3k 1.0× 1.6k 1.9× 609 1.0× 894 1.7× 618 1.4× 77 5.0k
Salvatore Papa 2.7k 1.2× 1.0k 1.2× 889 1.4× 1.5k 2.8× 242 0.6× 51 4.5k
Concetta Bubici 2.2k 1.0× 822 0.9× 756 1.2× 1.1k 2.1× 195 0.5× 29 3.8k
Michitaka Ozaki 2.0k 0.9× 918 1.1× 778 1.2× 520 1.0× 498 1.2× 133 4.7k
Soo‐Jong Um 1.9k 0.8× 504 0.6× 562 0.9× 423 0.8× 405 0.9× 100 3.5k
Julián Gómez-Cambronero 2.1k 0.9× 1.0k 1.2× 546 0.9× 400 0.8× 510 1.2× 113 3.6k
You Mie Lee 3.4k 1.5× 506 0.6× 777 1.2× 1.5k 2.8× 201 0.5× 119 5.0k
Lesley M. Forrester 2.7k 1.2× 566 0.6× 499 0.8× 383 0.7× 220 0.5× 86 4.5k
Hidetoshi Hayashi 3.2k 1.4× 805 0.9× 750 1.2× 572 1.1× 320 0.7× 131 5.2k
Hayato Hikita 1.7k 0.7× 492 0.6× 600 0.9× 723 1.4× 178 0.4× 133 3.6k

Countries citing papers authored by Quansheng Zhou

Since Specialization
Citations

This map shows the geographic impact of Quansheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quansheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quansheng Zhou more than expected).

Fields of papers citing papers by Quansheng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quansheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quansheng Zhou. The network helps show where Quansheng Zhou may publish in the future.

Co-authorship network of co-authors of Quansheng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Quansheng Zhou. A scholar is included among the top collaborators of Quansheng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quansheng Zhou. Quansheng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Mei, Yan Guo, Yu Chen, et al.. (2023). Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways. Cellular Oncology. 47(2). 657–676. 2 indexed citations
2.
Meng, Mei, Juntao Liu, Xiaoxiao Song, et al.. (2023). Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes. Biochemical Pharmacology. 217. 115833–115833. 6 indexed citations
3.
Yang, Ping, et al.. (2022). Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer. Frontiers in Oncology. 12. 864159–864159. 13 indexed citations
4.
Zhang, Mengli, Mei Meng, Yuxi Liu, et al.. (2021). Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins. Breast Cancer Research. 23(1). 21 indexed citations
5.
Zhao, Zhe, Bin Zhang, Tong Zhang, et al.. (2021). Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis. Biochemical Pharmacology. 185. 114423–114423. 11 indexed citations
7.
Zheng, Nana, Bin Zhang, Mei Meng, et al.. (2016). Thrombomodulin reduces tumorigenic and metastatic potential of lung cancer cells by up-regulation of E-cadherin and down-regulation of N-cadherin expression. Biochemical and Biophysical Research Communications. 476(4). 252–259. 18 indexed citations
8.
Pan, Yanyan, Mei Meng, Nana Zheng, et al.. (2016). Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells. Biochemical Pharmacology. 126. 34–50. 33 indexed citations
9.
Yu, Di, Zhifei Cao, Meimei Bao, et al.. (2014). Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms. Toxicology Letters. 226(3). 328–336. 31 indexed citations
10.
Zhou, Quansheng. (2013). Effect of ranunculus japonicus components D1 on vasculogenic mimicry of human gastric cancer cell MGC803. Zhongguo yaolixue tongbao. 2 indexed citations
11.
Liu, Ruifang, Bingxue Shang, Zhifei Cao, et al.. (2012). A Monoclonal Antibody SZ-117 That Recognizes Filamin A Derived from Tumor Cells. Hybridoma. 31(3). 214–218. 1 indexed citations
12.
Shang, Bingxue, Gaochuan Zhang, Yanyan Pan, & Quansheng Zhou. (2012). Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy. Cancer Microenvironment. 5(3). 211–223. 8 indexed citations
13.
Yang, Jianfeng, et al.. (2012). Molecular Regulation of Lymphangiogenesis in Development and Tumor Microenvironment. Cancer Microenvironment. 5(3). 249–260. 14 indexed citations
14.
Zhang, Gaochuan, Bingxue Shang, Ping Yang, et al.. (2011). Induced Pluripotent Stem Cell Consensus Genes: Implication for the Risk of Tumorigenesis and Cancers in Induced Pluripotent Stem Cell Therapy. Stem Cells and Development. 21(6). 955–964. 44 indexed citations
15.
Zhou, Quansheng, et al.. (2005). Phospholipid Scramblase 1 Binds to the Promoter Region of the Inositol 1,4,5-Triphosphate Receptor Type 1 Gene to Enhance Its Expression. Journal of Biological Chemistry. 280(41). 35062–35068. 77 indexed citations
16.
Dong, Beihua, Quansheng Zhou, Ji Zhao, et al.. (2004). Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon. Journal of Virology. 78(17). 8983–8993. 101 indexed citations
17.
Zhou, Quansheng, et al.. (2000). Identification of three new members of the phospholipid scramblase gene family. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1467(1). 244–253. 125 indexed citations
18.
Zhao, Ji, et al.. (1998). Identity of the Residues Responsible for the Species-restricted Complement Inhibitory Function of Human CD59. Journal of Biological Chemistry. 273(17). 10665–10671. 29 indexed citations
19.
Zhou, Quansheng, Ji Zhao, James G. Stout, et al.. (1997). Molecular Cloning of Human Plasma Membrane Phospholipid Scramblase. Journal of Biological Chemistry. 272(29). 18240–18244. 335 indexed citations
20.
Zhou, Quansheng, Gary Hellermann, & Larry P. Solomonson. (1995). Nitric oxide release from resting human platelets. Thrombosis Research. 77(1). 87–96. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026